Mode
Text Size
Log in / Sign up

Carbamazepine linked to lower postoperative pain scores in tentorial meningioma resectionCould an old seizure drug help people recover from brain surgery with less pain?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider these carbamazepine findings preliminary due to retrospective design and small sample size.

This retrospective cohort study evaluated 42 consecutive patients who underwent surgical resection for tentorial meningiomas at a single center. The intervention group (n=20) received carbamazepine (CBZ) at 200 mg twice daily postoperatively, while the control group (n=22) received nonsteroidal anti-inflammatory drugs or opioids as needed for pain management. The primary outcome was not reported.

Patients in the CBZ group reported significantly lower pain scores on postoperative day 2 (p < 0.05) and day 7 (p < 0.05) compared to controls. The CBZ group also showed shorter hospital stays and lower hospital costs, but these differences were not statistically significant. No effect sizes or absolute numbers were reported for these outcomes.

Safety and tolerability data were not reported. The study has important limitations including its retrospective design, small sample size of 42 patients, and lack of reported confidence intervals or effect sizes. Funding and conflicts of interest were not reported.

This single-center retrospective study suggests an association between postoperative carbamazepine and reduced pain scores after tentorial meningioma resection, but cannot establish causation. The findings should be interpreted cautiously due to methodological limitations and require confirmation in prospective, controlled trials before clinical application can be considered.

Recovering from brain surgery is tough, and managing the pain is a critical part of healing. A small study looked back at 42 patients who had surgery for a specific brain tumor called a tentorial meningioma. It found that those given carbamazepine—a medication typically used for seizures—reported significantly lower pain scores on the second and seventh days after their operation compared to patients who used standard pain relievers like NSAIDs or opioids.

The study also noted that the carbamazepine group tended to have shorter hospital stays and lower costs, though these differences weren't strong enough to be considered statistically significant. The researchers didn't report on side effects or how well patients tolerated the drug in this setting.

It's important to view these findings as a promising signal, not a proven solution. The study was retrospective, meaning it analyzed past records rather than testing the drug in a controlled trial. With only 42 patients from one hospital, the results are preliminary. We don't know if carbamazepine actually caused the pain relief or if other factors were at play. More rigorous research is needed to see if this effect holds up.

What this means for you:
An old seizure drug was linked to less pain after brain surgery in a small, preliminary study.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundPostoperative pain management is critical for patients undergoing surgery for tentorial meningiomas due to the involvement of trigeminal nerve innervation in this region, which often results in severe pain. This study aimed to evaluate the efficacy and safety of carbamazepine (CBZ) in reducing postoperative pain, analgesic consumption, and hospital stay in these patients.MethodsThis retrospective study included consecutive patients with tentorial meningiomas who underwent surgical resection between March 2021 and August 2023 at the Second Affiliated Hospital of Zhejiang University. Patients were divided into two groups, with the control group receiving nonsteroidal anti-inflammatory drugs (NSAIDs) or opioids as needed for pain management, while the CBZ group was additionally treated with CBZ at a dosage of 200 mg twice daily postoperatively. Data collected included baseline demographics, postoperative inflammatory markers, liver function, length of hospital stay, total hospital charges, analgesic consumption, and daily pain score.ResultsA total of 42 patients were included in the study, with 22 in the control group and 20 in the CBZ group. Although the CBZ group had shorter hospital stays and lower costs, these differences were not statistically significant. The CBZ group reported significantly lower pain scores on postoperative days 2 and 7 (p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.